Showing results (1-10 of 402) with videos related to
Sort By:
Pageof 41
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1996
Select transition zone prostate cancers may be radiocurable despite markedly elevated prostate-specific antigen levelsA V D'Amico, I KaplanOncology (Williston Park, N.Y.)|September 11, 2001
Combined-modality staging for localized adenocarcinoma of the prostateA V D'AmicoMagnetic Resonance Imaging Clinics of North America|August 1, 1996
The role of MR imaging in the selection of therapy for prostate cancerA V D'AmicoHematology/Oncology Clinics of North America|June 1, 1996
What is the optimal patient selection for combined androgen ablative and radiation therapy? The role of combined modality stagingA V D'AmicoInternational Journal of Radiation Oncology, Biology, Physics|February 15, 2001
The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancerA V D'Amico, D Schultz, B Silver, et al.International Journal of Radiation Oncology, Biology, Physics|March 15, 1997
Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/mlA V D'Amico, R Whittington, I Kaplan, et al.JAMA|September 9, 2000
Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancerA V D'Amico, D Schultz, M Loffredo, et al.Cancer|January 28, 1998
Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliterA V D'Amico, R Whittington, I Kaplan, et al.International Journal of Radiation Oncology, Biology, Physics|October 6, 1997
Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTVA V D'Amico, R Whittington, I Kaplan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still outA V D'Amico, C N ColemanPageof 41